A New Resource To Help Advance Patient-Focused Drug Development With DHTs

By Christine Guo, Ph.D.

The imperative to streamline clinical trials for faster, more effective patient treatments underscores the necessity of a patient-centric approach, ensuring treatments not only work but also enhance the quality of life and adherence to therapy for improved health outcomes.

At ActiGraph, witnessing the transformative impact of wearable digital health technologies (DHTs) in numerous trials has inspired us to launch the Patient-Focused Digital Measure Report Database. This resource will leverage patient-reported data from the FDA's Patient-Focused Drug Development Initiative to highlight specific indications where DHTs can provide meaningful, patient-centric measures.

By offering actionable insights and indication-specific reports, including symptom details and relevant digital measures, we aim to facilitate the integration of digital endpoints into clinical research seamlessly. Learn more by reading the full article below.